Connection
Kelly Maloney to Antibodies, Bispecific
This is a "connection" page, showing publications Kelly Maloney has written about Antibodies, Bispecific.
|
|
Connection Strength |
|
 |
|
 |
|
0.180 |
|
|
|
-
Keating AK, Gossai N, Phillips CL, Maloney K, Campbell K, Doan A, Bhojwani D, Burke MJ, Verneris MR. Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia. Blood Adv. 2019 07 09; 3(13):1926-1929.
Score: 0.180